Answers are grounded in this paper and cite their sources.
Country-level estimates of respiratory syncytial virus (RSV) burden are scarce in low- and middle-income countries (LMICs), particularly for hospital admissions and deaths. We modelled country- and age-specific RSV-associated acute lower respiratory infection (ALRI) incidence and hospital admission rates, and RSV-attributable and RSV-associated all-cause mortality rates, among children under five across 135 LMICs. RSV-associated ALRI incidence ranged from 38.9 to 80.5 per 1,000 person-years and was highest in southern Africa (Botswana, South Africa and Eswatini). RSV-associated ALRI hospital admission rates ranged from 0.8 to 23.2 per 1,000 person-years and were highest in the Democratic People’s Republic of Korea, Tajikistan and Ukraine. RSV-attributable and RSV-associated mortality rates ranged from 0.5 to 52.9 and from 1.1 to 120.9 per 100,000 person-years, respectively, with the highest rates in sub-Saharan Africa, including Nigeria, Somalia and Chad. These comparable estimates help fill country-level evidence gaps and can inform equitable prioritisation of RSV immunisation.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: